EventsThe 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response
Published
This submission belongs to the session 8. Poster of the event The 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response
Published date
29 Jan, 2021
Citation
Wafaa S Ramadan, Maha Saber Ayad, Rifat Hamoudi, Amina Laham, Varsha Menon, Lama Lozon, Hajjaj Abdu-Allah, Abdel-Nasser El-Shorbagi, Hamadeh Tarazi, Raafat El-Awady, 5-aminosalicylate–4-thiazolinone hybrid derivatives: A potent modulator of DNA damage response and G2/M cell cycle arrest via ATM/ATR pathway and Cyclin-CDK complex, in Proceedings of The 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response, 1 February–14 February 2021, MDPI: Basel, Switzerland, doi: 10.3390/IECC2021-09188
Share
Email
Facebook
Twitter
LinkedIn

5-aminosalicylate–4-thiazolinone hybrid derivatives: A potent modulator of DNA damage response and G2/M cell cycle arrest via ATM/ATR pathway and Cyclin-CDK complex

image
Varsha Menon 3
Lama Lozon 1
Hajjaj Abdu-Allah 4
Hamadeh Tarazi 6
1. Sharjah Institute for Medical Research and college of Medicine, University of Sharjah, Sharjah, United Arab Emirates
2. College of Medicine, University of Sharjah, Sharjah, United Arab Emirates
3. Sharjah Institute for Medical Research, University of Sharjah, Sharjah, United Arab Emirates
4. Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Assiut University, Assiut, Egypt
5. College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
6. Sharjah Institute for Medical Research and college of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates
Abstract
Keywords
5-aminosalicylate–4-thiazolinone
DNA damage
ATM/ATR
Cell cycle
Cyclin-CDKs
Apoptosis
Manuscript
Poster
sciforum-041979.pdf